 | • レポートコード：MRC2203A037 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、世界の生体医療用牛由来コラーゲン市場規模が、年平均9.7％成長すると予測しています。本市場調査レポートでは、生体医療用牛由来コラーゲンの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、用途別（骨移植代替物、コラーゲン由来スキャホールド、止血鉗子、代用皮膚、軟骨修復）分析、地域別（北米、ヨーロッパ、アジア太平洋、その他地域）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の生体医療用牛由来コラーゲン市場規模：用途別（骨移植代替物、コラーゲン由来スキャホールド、止血鉗子、代用皮膚、軟骨修復） ・世界の生体医療用牛由来コラーゲン市場規模：地域別（北米、ヨーロッパ、アジア太平洋、その他地域） ・競争状況（Symatese、Darling Ingredients Inc. (Rousselot)、Foodmate Co. Ltd、…） ・市場機会・将来傾向 |
The Bovine-based Collagen for Biomedical Applications market studied was projected to grow with a CAGR of nearly 9.7% over the forecast period. The major factor attributing to the growth of the market is the increasing demand for bovine-based collagen in biomedical applications to treat various medical conditions like arthritis, osteoporosis and improving skin health. Furthermore, the increasing demand for dental, orthopedic surgeries for reconstruction, and rise in research and development of wound healing and regenerative medicines is boosting the market growth. However, the high risk of disease transmission is the major drawback of market growth.
Key Market Trends
Bone-graft Substitute Segment Accounted for a Dominant Share of the Market
- A bone substitute can be defined as a synthetic, inorganic or biologically organic combination which can be inserted for the treatment of a bone defect instead of autogenous or allogenous bone. Bone is mainly made of collagen and carbonate substituted hydroxyapatite. An implant manufactured from such components is likely to behave better. The ductile properties of collagen help to increase the poor fracture toughness of hydroxyapatites.
- The factors boosting the segment growth are increasing prevalence of bone related diseases like osteoporosis and arthritis. According to International Osteoporosis Foundation, in 2018 it is estimated that over 200 million people globally suffer from osteoporosis. Approximately 30% of all postmenopausal women have osteoporosis in the United States and in Europe. Aging of populations worldwide will be responsible for a major increase in the incidence of osteoporosis in postmenopausal women and indirectly boosting the market growth.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, high prevalence of bone-related diseases in the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase the market growth. In this region the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market.
Competitive Landscape
The Bovine-based Collagen for Biomedical Applications market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are BBI Solutions, Symatese, Rousselot , FOODMATE CO., LTD., Botiss biomaterials GmbH, Medtronic, Taxus Cardium, KYERON, Collagen Matrix, Inc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Demand for Bovine-Based Collagen to Treat Various Disease
4.2.2 Increasing demand for dental, orthopedic surgeries
4.2.3 Ongoing R&D for the Development of Wound Healing & Regenerative Medicines
4.3 Market Restraints
4.3.1 High Risk of Disease Transmission
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Bone Graft Substitutes
5.1.2 Collagen-based Scaffolds
5.1.3 Hemostats
5.1.4 Skin Substitutes
5.1.5 Cartilage Repairs
5.1.6 Others
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Rest of World
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Symatese
6.1.2 Darling Ingredients Inc. (Rousselot)
6.1.3 Foodmate Co. Ltd
6.1.4 Botiss Biomaterials GmbH
6.1.5 Medtronic PLC
6.1.6 Kyeron
6.1.7 Collagen Matrix Inc.
6.1.8 Collagen Solutions PLC
6.1.9 Titan Biotech
7 MARKET OPPORTUNITIES AND FUTURE TRENDS